Menu

• Ask a Health Expert about DIABETES WITH HYPEROSMOLARITY
• Post Your Side Effect related to DIABETES WITH HYPEROSMOLARITY
• DIABETES WITH HYPEROSMOLARITY and FDA Warnings
• DIABETES WITH HYPEROSMOLARITY in Patients Wiki
• Report DIABETES WITH HYPEROSMOLARITY in Drug Side Effect Survey

DIABETES WITH HYPEROSMOLARITY side effect

What is DIABETES WITH HYPEROSMOLARITY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Velcade Side Effects Report #5339313-8
Physician from FRANCE reported VELCADE problem on May 14, 2007. Male patient, 58 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: diabetes with hyperosmolarity, . VELCADE dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Decadron Side Effects Report #5744390-6
DECADRON problem was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2008. Female patient, 73 years of age, weighting 123.0 lb, was diagnosed with non-small cell lung cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: chest pain, diabetes with hyperosmolarity, electrocardiogram q waves, hypertensive crisis, hyponatraemia, treatment noncompliance, . DECADRON dosage: unknown. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5588318-0
Physician from UNITED KINGDOM reported OLANZAPINE problem on Jan 04, 2008. Male patient was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, decreased appetite, diabetes with hyperosmolarity, neglect of personal appearance, renal failure acute, rhabdomyolysis, thirst decreased, . OLANZAPINE dosage: 10 MG, UNK. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5348260-7
VELCADE problem was reported by a Physician from FRANCE on May 24, 2007. Male patient, 58 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, atrial fibrillation, diabetes with hyperosmolarity, pneumonia, . VELCADE dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.